November 5, 2012Drugs/Medicineadmin Prior to this approval, surgical intervention was the only option in Europe for these tuberous sclerosis complex (TSC) patients[1],[2] Kidney tumors, or renal angiomyolipomas, affect up to 80% of patients ...
